Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Upregulation of Shiga toxin receptor CD77/Gb3 and interleukin-1β expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms.

Hagel C, Krasemann S, Löffler J, Püschel K, Magnus T, Glatzel M.

Brain Pathol. 2015 Mar;25(2):146-56. doi: 10.1111/bpa.12166.

PMID:
24989888
2.

The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.

Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C.

Brain. 2012 Jun;135(Pt 6):1850-9. doi: 10.1093/brain/aws090.

PMID:
22539260
3.

Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.

Takahashi K, Funata N, Ikuta F, Sato S.

J Neuroinflammation. 2008 Mar 21;5:11. doi: 10.1186/1742-2094-5-11.

4.

Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.

Bellmeyer A, Cotton C, Kanteti R, Koutsouris A, Viswanathan VK, Hecht G.

Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G576-81. doi: 10.1152/ajpgi.00050.2009.

5.

Cerebral magnetic resonance imaging findings in adults with haemolytic uraemic syndrome following an infection with Escherichia coli, subtype O104:H4.

Löbel U, Eckert B, Simova O, Meier-Cillien M, Kluge S, Gerloff C, Röther J, Magnus T, Fiehler J.

Clin Neuroradiol. 2014 Jun;24(2):111-9. doi: 10.1007/s00062-013-0231-0.

PMID:
23811994
6.

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G; HUS Investigation Team..

N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483.

7.

Thalamic involvement in patients with neurologic impairment due to Shiga toxin 2.

Meuth SG, Göbel K, Kanyshkova T, Ehling P, Ritter MA, Schwindt W, Bielaszewska M, Lebiedz P, Coulon P, Herrmann AM, Storck W, Kohmann D, Müthing J, Pavenstädt H, Kuhlmann T, Karch H, Peters G, Budde T, Wiendl H, Pape HC.

Ann Neurol. 2013 Mar;73(3):419-29. doi: 10.1002/ana.23814.

PMID:
23424019
8.

Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.

Gunzer F, Hennig-Pauka I, Waldmann KH, Sandhoff R, Gröne HJ, Kreipe HH, Matussek A, Mengel M.

Am J Clin Pathol. 2002 Sep;118(3):364-75.

PMID:
12219778
9.

Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.

Müthing J, Schweppe CH, Karch H, Friedrich AW.

Thromb Haemost. 2009 Feb;101(2):252-64. Review.

PMID:
19190807
10.

Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.

Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, Müller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RA, Wegscheider K, Kluge S.

Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.

PMID:
23660733
11.

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?

Bielaszewska M, Köck R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, Mellmann A.

PLoS One. 2007 Oct 10;2(10):e1024.

12.

Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome.

Kuroda M, Shimizu M, Inoue N, Ikeno I, Nakagawa H, Yokoi A, Niida Y, Konishi M, Kaneda H, Igarashi N, Yamahana J, Taneichi H, Kanegane H, Ito M, Saito S, Furuichi K, Wada T, Nakagawa M, Yokoyama H, Yachie A.

Neurochem Int. 2015 Jun-Jul;85-86:24-30. doi: 10.1016/j.neuint.2015.04.003.

PMID:
25895963
13.

Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli.

Garcia A, Bosques CJ, Wishnok JS, Feng Y, Karalius BJ, Butterton JR, Schauer DB, Rogers AB, Fox JG.

J Infect Dis. 2006 Apr 15;193(8):1125-34.

PMID:
16544253
14.

Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111.

Matano S, Inamura K, Konishi M, Okumura T, Kawai H, Okamura T, Takata Y, Yamada K, Obata M, Nagata H, Muramoto Y, Sugimoto T.

J Infect Chemother. 2012 Aug;18(4):558-64. doi: 10.1007/s10156-011-0336-9.

PMID:
22080202
16.

Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome.

Page AV, Liles WC.

Med Clin North Am. 2013 Jul;97(4):681-95, xi. doi: 10.1016/j.mcna.2013.04.001. Review.

PMID:
23809720
17.

Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.

Bentancor LV, Mejías MP, Pinto A, Bilen MF, Meiss R, Rodriguez-Galán MC, Baez N, Pedrotti LP, Goldstein J, Ghiringhelli PD, Palermo MS.

MBio. 2013 Oct 1;4(5):e00501-13. doi: 10.1128/mBio.00501-13.

18.

Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.

Poolpol K, Orth-Höller D, Speth C, Zipfel PF, Skerka C, de Córdoba SR, Brockmeyer J, Bielaszewska M, Würzner R.

Mol Immunol. 2014 Mar;58(1):77-84. doi: 10.1016/j.molimm.2013.11.009.

PMID:
24317278
19.

Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.

Stearns-Kurosawa DJ, Oh SY, Cherla RP, Lee MS, Tesh VL, Papin J, Henderson J, Kurosawa S.

Am J Pathol. 2013 Apr;182(4):1227-38. doi: 10.1016/j.ajpath.2012.12.026.

20.
Items per page

Supplemental Content

Support Center